Rhoen Klinikum AG (RHK) Given a €25.00 Price Target by S&P Global Analysts

Rhoen Klinikum AG (ETR:RHK) has been assigned a €25.00 ($29.07) target price by stock analysts at S&P Global in a report issued on Friday. The brokerage currently has a “sell” rating on the stock. S&P Global’s price objective indicates a potential downside of 17.44% from the company’s current price.

Several other analysts also recently weighed in on RHK. Berenberg Bank set a €29.15 ($33.90) price objective on Rhoen Klinikum AG and gave the stock a “neutral” rating in a research report on Monday, November 6th. Baader Bank set a €24.00 ($27.91) price objective on Rhoen Klinikum AG and gave the stock a “neutral” rating in a research report on Friday. Independent Research GmbH set a €28.00 ($32.56) price objective on Rhoen Klinikum AG and gave the stock a “neutral” rating in a research report on Monday, August 14th. Warburg Research set a €26.30 ($30.58) price objective on Rhoen Klinikum AG and gave the stock a “neutral” rating in a research report on Tuesday, November 7th. Finally, Commerzbank Ag set a €25.00 ($29.07) target price on Rhoen Klinikum AG and gave the company a “neutral” rating in a research report on Friday. Four investment analysts have rated the stock with a sell rating and six have given a hold rating to the stock. The stock presently has an average rating of “Hold” and an average target price of €24.49 ($28.48).

Shares of Rhoen Klinikum AG (ETR:RHK) opened at €30.28 ($35.21) on Friday. Rhoen Klinikum AG has a 1 year low of €22.66 ($26.35) and a 1 year high of €30.65 ($35.64).

TRADEMARK VIOLATION WARNING: “Rhoen Klinikum AG (RHK) Given a €25.00 Price Target by S&P Global Analysts” was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.chaffeybreeze.com/2017/11/12/rhoen-klinikum-ag-rhk-given-a-25-00-price-target-by-sp-global-analysts.html.

Rhoen Klinikum AG Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhoen Klinikum AG (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply